NOT FOR UK USE ? NOT INTENDED FOR UK MEDIA LEO Pharma A/S, a global leader in medical dermatology, today announced that Swissmedic, Switzerland's national regulatory agency for approving and ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitis ZORYVE, a next-generation topical phosphodiesterase-4 ...

Does your skin feel as dry as a desert no matter how much moisturiser you use? It’s time to step up your skincare game.

Retinal, a derivative of vitamin A, works in various ways to improve the appearance of your skin. Here’s how to determine how ...

The Company submitted an sNDA for ZORYVE foam for scalp and body psoriasis to the FDA based on the positive results from the pivotal ARRECTOR Phase 3 trial and a Phase 2b trial, which was accepted by ...

Military personnel encounter the same allergens and irritants as their civilian counterparts and are just as likely to develop contact dermatitis from common exposures encountered in everyday life.

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

Organon said the Food and Drug Administration extended by three months its review of an application seeking expanded approval of the healthcare company's recently acquired skin-care cream Vtama.

Indication: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for the topical treatment of ... in the nose and throat), contact dermatitis (skin rash or irritation ...

VTAMA cream is a non-steroidal once-daily topical treatment. The safety and effectiveness ... (pain or swelling in the nose and throat), contact dermatitis (skin rash or irritation, including ...